PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • As noted by Novartis, it will be the only meningitis-B vaccine approved for all age groups, including infants.According to Reuters, analysts are projecting that peak sales of the drug will top out around $600 million to $700 million.
http://www.w3.org/ns/prov#wasQuotedFrom
  • fool.com